These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 11903686)

  • 21. [A case of pneumomediastinum during BEP (bleomycin, etoposide, cisplatin) chemotherapy for testicular cancer].
    Noguchi G; Ota J; Ishigaki H; Onuki T; Kato Y; Moriyama M
    Hinyokika Kiyo; 2013 Aug; 59(8):545-9. PubMed ID: 23995535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.
    Garcia-del-Muro X; Maroto P; Gumà J; Sastre J; López Brea M; Arranz JA; Lainez N; Soto de Prado D; Aparicio J; Piulats JM; Pérez X; Germá-Lluch JR
    J Clin Oncol; 2008 Nov; 26(33):5416-21. PubMed ID: 18936476
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
    Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
    Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [BEP (bleomycin, etoposide, cisplatin) therapy for testicular tumors].
    Mori Y; Shima H; Ihara H; Yabumoto H; Iwasaki A; Yoshioka M; Ikoma F
    Hinyokika Kiyo; 1992 Oct; 38(10):1139-42. PubMed ID: 1282774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of bleomycin pulmonary toxicity on the outcomes of patients with germ cell tumors.
    Maruyama Y; Sadahira T; Mitsui Y; Araki M; Wada K; Tanimoto R; Kobayashi Y; Watanabe M; Watanabe T; Nasu Y
    Med Oncol; 2018 Apr; 35(6):80. PubMed ID: 29700638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Completion and toxicity of induction chemotherapy for metastatic testicular cancer: an updated evaluation of Japanese patients.
    Kawai K; Ando S; Hinotsu S; Oikawa T; Sekido N; Miyanaga N; Shimazui T; Akaza H
    Jpn J Clin Oncol; 2006 Jul; 36(7):425-31. PubMed ID: 16790450
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
    Harousseau JL; Witz B; Lioure B; Hunault-Berger M; Desablens B; Delain M; Guilhot F; Le Prise PY; Abgrall JF; Deconinck E; Guyotat D; Vilque JP; Casassus P; Tournilhac O; Audhuy B; Solary E
    J Clin Oncol; 2000 Feb; 18(4):780-7. PubMed ID: 10673519
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocompetence in non-seminomatous testicular cancer patients before any treatment and one year after completion of therapy.
    Kastelan Z; Pasini J; Derezić D; Lukac J; Kusić Z; Mrazovac D; Sosić H; Kastelan M
    Anticancer Res; 2004; 24(5B):3251-5. PubMed ID: 15510619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dose intensification in the treatment of patients with testicular germ cell tumours.
    O'Reilly SM; Smith DB; Newlands ES; Rustin GJ
    Eur J Cancer; 1994; 30A(5):723. PubMed ID: 7521654
    [No Abstract]   [Full Text] [Related]  

  • 30. Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group.
    de Wit R; Stoter G; Kaye SB; Sleijfer DT; Jones WG; ten Bokkel Huinink WW; Rea LA; Collette L; Sylvester R
    J Clin Oncol; 1997 May; 15(5):1837-43. PubMed ID: 9164193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intra-arterial infusion chemotherapy for liver metastases of testicular tumors: report of two cases].
    Tanase K; Tawada M; Moriyama N; Muranaka K
    Hinyokika Kiyo; 2000 Nov; 46(11):823-7. PubMed ID: 11193306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are 3 cycles of bleomycin, etoposide and cisplatin or 4 cycles of etoposide and cisplatin equivalent optimal regimens for patients with good risk metastatic germ cell tumors of the testis? The need for a randomized trial.
    Culine S; Theodore C; Terrier-Lacombe MJ; Droz JP
    J Urol; 1997 Mar; 157(3):855-8; discussion 858-9. PubMed ID: 9072585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of testicular cancer in which complete response was achieved with chemotherapy including cisplatin, etoposide and bleomycin, and salvage surgery].
    Uekado Y; Matsumoto M; Inagaki T; Shintani Y
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):543-6. PubMed ID: 7510465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of metastatic germ-cell testicular tumours with bleomycin, etoposide and cis-platin (BEP).
    Peckham MJ; Barrett A; Liew KH; Horwich A; Robinson B; Dobbs HJ; McElwain TJ; Hendry WF
    Br J Cancer; 1983 May; 47(5):613-9. PubMed ID: 6189504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
    de Wit R; Louwerens M; de Mulder PH; Verweij J; Rodenhuis S; Schornagel J
    Int J Cancer; 1999 Dec; 83(6):831-3. PubMed ID: 10597204
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cisplatin-based chemotherapy after retroperitoneal lymph node dissection in patients with pathological stage II nonseminomatous germ cell tumors.
    Culine S; Theodore C; Farhat F; Bekradda M; Terrier-Lacombe MJ; Droz JP
    J Surg Oncol; 1996 Mar; 61(3):195-8. PubMed ID: 8637206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group.
    Albers P; Siener R; Krege S; Schmelz HU; Dieckmann KP; Heidenreich A; Kwasny P; Pechoel M; Lehmann J; Kliesch S; Köhrmann KU; Fimmers R; Weissbach L; Loy V; Wittekind C; Hartmann M;
    J Clin Oncol; 2008 Jun; 26(18):2966-72. PubMed ID: 18458040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term efficacy of two cycles of BEP regimen in high-risk stage I nonseminomatous testicular germ cell tumors with embryonal carcinoma and/or vascular invasion.
    Chevreau C; Mazerolles C; Soulié M; Gaspard MH; Mourey L; Bujan L; Plante P; Rischmann P; Bachaud JM; Malavaud B
    Eur Urol; 2004 Aug; 46(2):209-14; discussion 214-5. PubMed ID: 15245815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A case of lung abscess during chemotherapy for testicular tumor].
    Hayashi Y; Miyago N; Takeda K; Yamaguchi Y; Nakayama M; Arai Y; Kakimoto K; Nishimura K
    Hinyokika Kiyo; 2014 May; 60(5):237-9. PubMed ID: 24894860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom.
    Fosså SD; Kaye SB; Mead GM; Cullen M; de Wit R; Bodrogi I; van Groeningen CJ; De Mulder PH; Stenning S; Lallemand E; De Prijck L; Collette L
    J Clin Oncol; 1998 Feb; 16(2):716-24. PubMed ID: 9469362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.